(Q41378447)

30 September 2017

title

Infectious Disease. How to bolster the antifungal pipeline (English)

1 reference

30 September 2017

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814567%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

David W Denning

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814567%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

26 March 2015

1 reference

30 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814567%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

347

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814567%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

6229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814567%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

1414-1416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814567%20AND%20SRC:MED&resulttype=core&format=json

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

Hidden killers: human fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

Decreased Infection-Related Mortality and Improved Survival in Severe Aplastic Anemia in the Past Two Decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

Systems-level antimicrobial drug and drug synergy discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

Fungal allergy in asthma-state of the art and research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6097

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.AAA6097

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25814567%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference